Balance Sheet
Cash Flow Statement
AmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in IntangiblesChange in IntangiblesChange in TaxesChange in TaxesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Stevanato Group S.p.A (STVN) Shares Issued (2024)

Stevanato Group S.p.A (STVN) reported Shares Issued of -$49419.9 for Q3 2024, up 93.55% on a QoQ basis from -$765667.1 in Q2 2024.

Stevanato Group S.p.A (STVN) has 1 years of Shares Issued data on file, last reported at -$49419.9 in Q3 2024.

  • Quarterly Shares Issued changed N/A year-over-year to -$49419.9 in Q3 2024, while the trailing twelve-month figure through Dec 2024 was $184.4 million (changed N/A YoY) and the FY2024 annual result came in at $181.4 million, changed N/A from the prior year.
  • Shares Issued rose to -$49419.9 in Q3 2024 per STVN's latest filing, from -$765667.1 in the prior quarter.
  • Across five years, Shares Issued topped out at $185.3 million in Q1 2024 and bottomed at -$765667.1 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 121.80 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 7.43 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 5.50 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 3.90 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 11.72 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 8.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 18.52 Mn
10 Stevanato Group S.p.A 5.73 Bn 5.59 Bn 88.04 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2024 -49,419.88
Sep 30, 2024 -49,419.88
Jun 30, 2024 -765,667.07
Jun 30, 2024 -765,667.07
Mar 31, 2024 185.26 Mn
Mar 31, 2024 185.26 Mn